Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins.
about
Novel approaches to develop Rift Valley fever vaccinesIRES-dependent replication of Venezuelan equine encephalitis virus makes it highly attenuated and incapable of replicating in mosquito cellsVaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and preventionRift valley fever: recent insights into pathogenesis and preventionTowards a safe, effective vaccine for Rift Valley fever virusA single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs.Development of a novel, single-cycle replicable rift valley Fever vaccine.Replicating and non-replicating viral vectors for vaccine developmentTechnical transformation of biodefense vaccines.Vaccines for viral hemorrhagic fevers--progress and shortcomingsRift valley fever vaccines.Pseudoinfectious Venezuelan equine encephalitis virus: a new means of alphavirus attenuation.Structural and functional elements of the promoter encoded by the 5' untranslated region of the Venezuelan equine encephalitis virus genome.An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep.Virus-like particle-based countermeasures against Rift Valley fever virus.A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity.An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus.
P2860
Q27027003-815A1AA7-C274-41C2-A26B-27635EDFC932Q27486518-CD2D316C-F84A-4A98-BE89-E65C82BC6A2DQ33617793-4B916799-69E5-48B0-A95F-038AEDF87E6FQ33960690-684FF62E-2707-4E56-8D5E-E55D606210FDQ34174444-AD6CDCE1-3258-4610-9BFC-6860060665FEQ34677989-C4A89F4D-A367-422C-ADF7-ABB4813B33F1Q35027744-1D7A6C03-8C5B-4429-A2C5-917814F95D41Q35126733-4FF60DFF-67D7-4FB3-919B-5331FF0BA8D7Q36464587-9F93032A-2F8E-4DCF-8BF3-70C129A4C787Q37058898-94ED8131-105A-42FE-8A11-319675DD2F22Q37096221-5A77E42B-95D6-47B9-BAD2-4495DD077215Q37393780-50B1A153-E284-48B6-8C6A-4F81B2E61218Q39230468-B1FCB9B5-71B3-47C8-9BDD-0AB09FE12CB7Q39839755-CF137C6A-6897-4AF6-9409-2D7A34383800Q40043424-8324642E-A0E7-4BF4-A5E8-0CAE889E6047Q40254473-9452A97B-2641-4FA6-A090-19FC6AE005BBQ40379142-9D71F549-61BB-4136-8FEF-E90B122F411BQ40398800-BEFE92C6-1780-4367-B7B0-6488487E9FBE
P2860
Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Comparative analysis of the al ...... ley fever virus glycoproteins.
@en
Comparative analysis of the al ...... ley fever virus glycoproteins.
@nl
type
label
Comparative analysis of the al ...... ley fever virus glycoproteins.
@en
Comparative analysis of the al ...... ley fever virus glycoproteins.
@nl
prefLabel
Comparative analysis of the al ...... ley fever virus glycoproteins.
@en
Comparative analysis of the al ...... ley fever virus glycoproteins.
@nl
P2093
P2860
P50
P1433
P1476
Comparative analysis of the al ...... ley fever virus glycoproteins.
@en
P2093
Eugenia Volkova
Nadezda Yun
Nathaniel Seth Linde
Olga Petrakova
Rodion Gorchakov
Slobodan Paessler
P2860
P304
P356
10.1016/J.VIROL.2007.04.014
P407
P577
2007-05-16T00:00:00Z